Scotland · NHS Scotland MSAN
Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml
MSAN(2025)30 · Level 2 · issued 18 Jun 2025
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Valid until: noted products are being discontinued | Discontinued | — |
| Levemir® Penfill® 100units/ml solution for injection 3ml cartridges are being discontinued; stock | Discontinued | — |
| 2. Clinical advice on the discontinuation of all Levemir® presentations is being produced and will | Discontinued | — |
| 3. TO NOTE: This is the third of three MSANs covering discontinuations of Novo Nordisk insulin | Discontinued | — |
| you need to register with the SPS website. Registration for access to the website is available to | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2025:30
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
36589ced9de57f6acd0c3c5815d3a9dd132d9367249a6705e0630729092c97besha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2025-30.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.